Both in Pharmaceuticals
Cue Biopharma vs MacroGenics
Over the past year CUE returned −1.5% and MGNX returned +42.6%; their daily moves had a correlation of -0.01.
CUE −1.5% MGNX +42.6%Growth of $1, one year, split-adjusted
| Metric | CUE | MGNX |
|---|---|---|
| Price | $20.39 | $2.41 |
| Market cap | $148.1M | $153.5M |
| Today | −4.96% | +1.26% |
| 1 month | −19.3% | −33.1% |
| 6 months | −33.0% | −23.0% |
| Year to date | +122.5% | +49.7% |
| 1 year | −1.5% | +42.6% |
| Revenue growth (YoY) | +166.7% | +378.0% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1943.2% | 59.4% |
| P/E (TTM) | — | — |
| Price / sales | 3.9× | 0.9× |
| Net cash | $16.4M | $173.3M |
| Dividend yield | — | — |
| Volatility (60d) | 137.3% | 113.9% |
| Short % of float | 12.2% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).